e-h EphrinB3-induced phosphorylation of EphA4 and EphB2 RTKs in OPCs [immunoprecipitation followed by WB, pTyr phosphorylated Eph-RTK, t-Eph total Eph-RTK, quantification of phosphorylated Eph-RTK relative to total Eph-RTK (ROD), n = 3: t test; EphA4 ***P < 0.05; EphB1 P > 0.1; EphB2 **P < 0.01; EphB3 P > 0.1]. i Furthermore, EphrinB3-induced RhoA activity in OPCs (24-h differentiation; quantification of RhoA-GTP relative to RhoA-GDP (ROD), n = 3: ANOVA; *P < 0.05). j-l Whilst Marcks is localized at the membrane in differentiating OPCs cultured on control substrates, EphrinB3-mediated activation of Pkc-α resulted in phosphorylation and membrane-to-cytosol translocation of Marcks. m EphrinB3 also inhibited the activation of Fak [quantification of phosphorylated (p-) Fak relative to total (t-)Fak: (ROD), n = 3; t test; **P < 0.001]. n, o Similar to MPE, EphrinB3 inhibited Nkx2.2 expression in OPCs (24-h differentiation, n = 3; ANOVA; ****P < 0.0001; Dunnett's post hoc test PLL vs. MPE: P < 0.001; PLL vs. EphrinB3: P < 0.001; 3-day differentiation, n = 3; ANOVA; ****P < 0.0001; Dunnett's post hoc test PLL vs. MPE: P < 0.001; PLL vs. EphrinB3: P < 0.001). p Proposed model of EphrinB3 signalling regulating OPC differentiation: the presence of EphrinB3 activates EphA4 and EphB2-RTKs. This results in activation of RhoA and Pkc-α signalling, both known to inhibit OPC differentiation. EphrinB3 also inhibits Fak signalling, a positive regulator of OPC differentiation. Failed differentiation is associated with reduced expression of Nkx2.2. Error bars ± SEM. Scale bar in ad = 40 μm, j-l = 20 μm
